Details for New Drug Application (NDA): 211121
✉ Email this page to a colleague
NDA 211121 describes NICARDIPINE HYDROCHLORIDE, which is a drug marketed by Amneal, Ani Pharms, Bionpharma, Epic Pharma Llc, Glenmark Pharms Ltd, Navinta Llc, Pharmobedient, Senores Pharms, Am Regent, Chengdu Shuode, Eugia Pharma, Hikma, Hikma Intl Pharms, Mankind Pharma, Micro Labs, Nanjing King Friend, Qilu Pharm Hainan, Somerset Theraps Llc, Sun Pharm, Inforlife, Caplin, and Cipla, and is included in twenty-six NDAs. It is available from twenty-four suppliers. Additional details are available on the NICARDIPINE HYDROCHLORIDE profile page.
The generic ingredient in NICARDIPINE HYDROCHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
The generic ingredient in NICARDIPINE HYDROCHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
Summary for 211121
| Tradename: | NICARDIPINE HYDROCHLORIDE |
| Applicant: | Eugia Pharma |
| Ingredient: | nicardipine hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 211121
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NICARDIPINE HYDROCHLORIDE | nicardipine hydrochloride | INJECTABLE;INJECTION | 211121 | ANDA | Eugia US LLC | 55150-183 | 55150-183-11 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-183-11) / 10 mL in 1 VIAL, SINGLE-DOSE (55150-183-02) |
| NICARDIPINE HYDROCHLORIDE | nicardipine hydrochloride | INJECTABLE;INJECTION | 211121 | ANDA | Eugia US LLC | 55150-183 | 55150-183-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-183-10) / 10 mL in 1 VIAL, SINGLE-DOSE (55150-183-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/10ML (2.5MG/ML) | ||||
| Approval Date: | Apr 8, 2021 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
